# XORTX Therapeutics Inc.: Form 6-K, filed Jul 14, 2022

- Company: [XORTX Therapeutics Inc.](/companies/xrtx.md) (CIK 1729214)
- Form: 6-K
- Filed: 2022-07-14
- Accepted by EDGAR: Jul 14, 2022, 11:03 ET
- Period: 2022-07-13
- Accession: 0001171843-22-004855
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1729214/000117184322004855/f6k_071422.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729214/000117184322004855/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729214/000117184322004855/f6k_071422.htm

Filed Jul 14, 2022.
Source: SEC EDGAR, the filing index for accession 0001171843-22-004855. Last ingested by Listed: Nov 14, 2026, 22:48 ET. No prices; not investment advice.
